11 results
10-K
2020 FY
PRAX
Praxis Precision Medicines Inc
17 Mar 21
Annual report
8:33am
to resolve allegations of non-compliance, contractual damages, reputational harm, diminished profits and future earnings and curtailment of operations, any … be subject to fines and penalties, litigation, and reputational harm in connection with our European activities. Further, the United Kingdom’s
10-Q
2020 Q3
PRAX
Praxis Precision Medicines Inc
23 Nov 20
Quarterly report
4:16pm
, reputational harm and diminished profits and future earnings.
Although we do not currently have any products on the market, upon commercialization of our … penalties, damages, fines, disgorgement, imprisonment, reputational harm, exclusion from participation in federal and state funded healthcare programs
424B4
uzbsh
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1/A
rpc llr5k
9 Oct 20
IPO registration (amended)
6:09am
S-1
6dvn5ucml3 akj
25 Sep 20
IPO registration
5:19pm
DRS/A
q77 fijcz
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
bylv6wzm3 yxpbe
22 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next